baber/WOPTO huggingface dataset:
Patent NZ-500375-A (NZ)
Title: A genotyping survey for characterising the presence of E2 and E3 allele or the absence of apolipoprotein E4 allele for determining the level of treatment medication for Alzheimer's patients
Inventor: POIRIER JUDES
IPC: C12Q1/68
Filed: 1995-04-26
Abstract: The use of an effective amount of a cholinomimetic agent for manufacture of medicaments for treating Alzheimer's patient by initially determining the presence of apolipoproteins E2 and E3 allele or the absence of apolipoprotein E4 allele from the peripheral tissues of a patient which is indicative of the degree of impairment in brain acetylcholine synthesis and nicotinic receptor activity, followed by the administration of an effective amount of the medicament. The cholinomimetic agent is selected from the group consisting of inhibitors of acetylcholine degradation, inducers of acetylcholine synthesis, acetylcholine agonists or mimics, and muscarinic M2-receptor antagonists.
Patent NZ-502217-A (NZ)
Title: Use of the SCP gene in the treatment and diagnosis of cancers
Inventor: SAHIN UGUR
IPC: C12Q1/68
Filed: 1998-06-25
Abstract: A previously identified protein, SCP-1, is described as a marker for cell transformation. Diagnostic and therapeutic uses of this protein and related molecules are taught. Also described is a method for identifying substances which are immunoreactive and indicative of pathological conditions, using normal cells as source material.
Patent NZ-504357-A (NZ)
Title: Apparatus for variable image printing on adhesive tape using thermal print head
Inventor: EWERT BRIAN C
IPC: B41J3/407
Filed: 1998-10-22
Abstract: An apparatus (210) for printing variable identifying information on thin, narrow adhesive tape (50).  In a particular application, the apparatus replaces a labeling station and is combined with a case sealing station to seal cases with adhesive sealing tape (50) on a conventional production line.  The apparatus (210) includes a variable image thermal printer (30).  The thermal printer preferably includes a thermal transfer print head and a thermal transfer ribbon (34) able to print through a release agent on the face of the tape.  The tape is dispensed from a tape unwind spool and is routed past the print head with the thermal transfer ribbon (43) positioned between the print head and the face of the tape, and the face of the tape opposite the print head.  The thermal transfer ribbon (34) is compatible with the physical characteristics and chemical composition of the tape (50).  The apparatus (210) can print any desired product codes, stock or lot numbers, bar codes, and shipping data onto the tape (50).  The variable image printer (30) is controlled from a standard operator control panel of a controller (48) integrated with the variable image printer (30).
Patent NZ-505830-A (NZ)
Title: Method and system for identifying one or more objects by generating an arbitrary two dimensional optically readable pattern
Inventor: TEL TEUNIS
IPC: G06K17/00
Filed: 1999-01-20
Abstract: A method and system for identifying one or more objects, a two-dimensional, optically readable pattern and an identification code are generated.  The pattern and the identification code are paired in one-to-one correspondence by means of a predetermined algorithm and are arbitrary.  A two-dimensional representation 4 of the pattern is provided on the object 10 or on a pattern support 6 connected thereto.  The identification code is stored together with associated identification information.  In order to identify the object, the representation of the pattern thereof is optically scanned and the associated identification code determined, by means of which the identification information can be determined.
Patent NZ-510672-A (NZ)
Title: Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
Inventor: ROSS HAMISH
IPC: A61K31/44
Filed: 1998-06-02
Abstract: A process for the preparation of a pharmaceutical composition that comprises 5-[4-[2-(N-methyl-N- (2-pyridyl) amino) ethoxy ] - benzyl ] thiazolidine-2, 4-dione (compound I) involving the following steps:  preparing a first composition of compound I in the range of 5 to 20 % weight and a first pharmaceutical carrier; then admixing the first composition with a second pharmaceutical carrier.
Patent NZ-511506-A (NZ)
Title: Remedies for bone metabolic errors comprising OCIF
Inventor: MOCHIZUKI SHINICHI
IPC: C07K14/705
Filed: 1999-10-28
Abstract: A bone-pathobolism treating agent comprising at least one substance selected from the group consisting of osteoclastogenesis inhibitory factor (OCIF), its homologues, and its variants and a polysaccharide or its derivatives (namely heparin, pectin and or carrageenan). Use of osteoclastogenesis inhibitory factor (OCIF), its homologues, and its variants and a polysaccharide or its derivatives for the preparation of a medicine for treating bone-pathobolism.
Patent NZ-514090-A (NZ)
Title: Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
Inventor: YOUNG AIPING H
IPC: A61P35/00
Filed: 2000-02-09
Abstract: Compounds and methods for modulating cell proliferation and inhibiting the proliferation and metastasis of neoplastic cells in a mammal are described. Compounds that may be used to modulate cell proliferation include antisense oligonucleotides complementary to regions of the mammalian ribonucleotide reductase genes.
Patent NZ-520574-A (NZ)
Title: Method of treating a surface of an object with a hydrophobin-containing solution
Inventor: DE VOCHT MARCEL LEO
IPC: G01N33/543
Filed: 2001-02-02
Abstract: The invention relates to a method of treating the surface of an object with a hydrophobin-containing solution. The method involves coating the surface of an object with a hydrophobin composition followed by heating at a temperature of at least 30° C.
Patent NZ-520975-A (NZ)
Title: New drug combinations containing a norepinephrine reuptake inhibitor and an antimuscarinic agent for treating nervous system disorders
Inventor: ROGOSKY KAREN
IPC: A61K31/535
Filed: 2001-01-23
Abstract: A composition comprising: (a) a pharmaceutically effective amount of one or more norepinephrine reuptake inhibitors or a pharmaceutically effective salt thereof; and (b) a pharmaceutically effective amount of one or more antimuscarinic agents or a pharmaceutically effective salt thereof is disclosed. This composition is useful in treating disorders or diseases of the central nervous system, and particularly useful in treating incontinence.
Patent NZ-521629-A (NZ)
Title: TACI as an anti-tumor agent
Inventor: AMBROSE CHRISTINE
IPC: C07K19/00
Filed: 2001-04-27
Abstract: A TACI reagent for use as a medicament for the prevention of a condition associated with undesired cell proliferation, wherein said undesired cell proliferation comprises at least one solid tumour and said medicament extends the mean survival time.
Patent NZ-522568-A (NZ)
Title: Substituted bicyclic derivatives for the treatment of abnormal cell growth
Inventor: KATH JOHN CHARLES
IPC: A61P5/28
Filed: 2001-06-14
Abstract: Disclosed are compounds of formula 1, wherein: m is from 0 to 3, p is from 0 to 4, each R1 and R2 is independently H or alkyl, R3 is -(CR1R2)t(4 to 10 membered heterocyclic), wherein t is an integer from 0 to 5, the heterocyclic group is optionally fused to a benzene ring of a cycloalkyl group, the -(CR1R2)t- of R3 optionally including a carbon-carbon double bond or triple bond wherein t is from 2 to 5, and R3 is optionally substituted by 1 to 5 R8 groups, R4 is -(CR16R17)m-Ca"C-(CR16R17)kR13 or -(CR16R17)m-C=C-(CR16R17)kR13, each R5 is independently halo, hydroxy, -NR1R2, alkyl, trifluoromethyl, alkoxy, trifluoromethoxy, -NR6C(O)R1, -C(O)NR6R7, -SO2NR6R7, -NR6C(O)NR7R1 or -NR6C(O)OR7, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of abnormal cell growth, such as cancer, in a mammal.
Patent NZ-523797-A (NZ)
Title: Improvements in or relating to waste containers
Inventor: MAFI BRIAN TULIMA
IPC: B65F1/14
Filed: 2003-05-23
Abstract: A compacting device comprising a body having a lower contacting surface and upper non-contacting surface upon which a handle means is positioned and a ventilation channel extending between the lower contacting surface and the upper non-contacting surface of said body wherein one or more projections extend from the lower contacting surface.
Patent NZ-529626-A (NZ)
Title: Adjustable seat for watercraft with thigh support adjustable relative to pelvis support
Inventor: MCDONOUGH ROBERT
IPC: B63B29/04
Filed: 2002-05-20
Abstract: A seat for a watercraft provides a separately adjustable thigh support and back support. The seat includes a pelvis support with a mount adapted to mount the pelvis support to the watercraft and a separately positionable thigh support pivotally mounted on the pelvis support. An adjustable back support includes a post pivotally mounted to the pelvis support and a backrest that moves vertically on the post. Means are provided for adjusting and setting the thigh support and back support at desired positions for optimal support and comfort. Preferably, a person can adjust the seat while fully seated in the seat.
Patent NZ-532268-A (NZ)
Title: Stain removing chewing gum and confectionery compositions, and methods of making and using the same
Inventor: LUO SHIUH JOHN
IPC: A23L29/10
Filed: 2001-03-01
Abstract: A stain removing chewing gum composition is described to contain a gum base comprising a core and an optional coating having at least one layer. At least one of the core and coating comprises a stain removing effective amount of at least one stain removing agent. These are selected from the group consisting of anionic and non-ionic surfactants, such as sulfated butyl oleate, medium and long chain fatty acid esters and salts, salts of fumaric acid, potassium glomate and lecithin. Exceptions are explained to be sodium stearate, sodium palmitate and organic acid esters of mono- and/or di-glycerides. The stain removing agent is disclosed to not be directly mixed with the gum base when producing the chewing gum composition which enables effective amount of the stain removing agent to be released from the composition. The agent is disclosed to be from about 0.2 to 2% by weight based on the total weight of the chewing gum composition, which is described to be in the form of a slab, stick, or a centerfill chewing gum composition having a centerfill and a gum portion. (62) Divided out of 520186
Patent NZ-533351-A (NZ)
Title: Pneumatic pressure regulator assembly
Inventor: NEFF ROBERT H
IPC: G05D16/10
Filed: 2002-11-20
Abstract: A pneumatic pressure regulator assembly including a regulator housing having an inlet adapted for fluid communication with a supply of pneumatic pressure, an outlet adapted to provide pneumatic pressure to a downstream pneumatically actuated device at a regulated pressure, and a regulator valve assembly. The regulator valve assembly has a valve member movably supported within the regulator housing between an open and a closed position. A piston assembly acts to bias the valve member to its open position when the outlet pressure is below a predetermined value. The piston assembly includes a pressure responsive surface defining a geometric shape with a major and a minor axis wherein the major axis is greater than the minor axis. The piston assembly is responsive to pneumatic pressure flowing between the inlet and the outlet to reduce the biasing force acting on the valve member such that the valve member moves to its closed position when the outlet pressure exceeds a predetermined value.
Patent NZ-534268-A (NZ)
Title: Lift belt and system
Inventor: HEINZ GUENTHER
IPC: B66B7/06
Filed: 2002-12-20
Abstract: A lift belt (10) having a ribbed profile (25) for engaging a pulley is disclosed. The belt has an elastomeric body with a width/thickness aspect ratio of greater than 1 and rib angles of 60°-120°, preferably 90°. A longitudinally extending tensile cord (15) is contained within the belt body. An electrical circuit may be connected to the cord to measure the load on the belt and detecting cord failure.
Patent NZ-534541-A (NZ)
Title: Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
Inventor: BART KARL-CHRISTIAN
IPC: C07F15/00
Filed: 2003-01-29
Abstract: Water-soluble porphyrin platinuim compounds of the tetraarylporphyrin platinum derivatives type or of the hematoporphyrin platinum derivatives type with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases is disclosed. In particular, the compounds are suitable for photodynamic anti-tumor therapy.
Patent NZ-538018-A (NZ)
Title: Woven fabric belt device
Inventor: ECKHARDT GERHARD
IPC: D21F1/00
Filed: 2003-05-28
Abstract: The invention relates to a woven fabric belt device, e.g. an endless wire belt for papermaking and pulping machines, in which a connecting device (7a'; 7b') is provided at atleast one end of the woven fabric belt (20', 21') and can be joined via a releasable joining means (9) to another connecting device (7b'; 7a') of the same or of another woven fabric belt. A number of specified longitudinal threads (2', 2'') are removed from the woven fabric (20') along a section (4', 4'') assigned to the end of the woven fabric belt. The sections (4', 4'') with the removed longitudinal threads (2', 2'') are arranged in an overlying manner on at least one side of the woven fabric belt (20', 21') in an area in front of the connecting device (7a'; 7b') so that these sections form a support (10'; 10'') for protecting the connecting devices (7a'; 7b') when the woven fabric belt is running over a working surface (AF). According to the invention, the sections (4') with the removed longitudinal threads (2', 2'') are woven around transversal threads (11', 12') and woven backwards therewith.
Patent NZ-538260-A (NZ)
Title: Use of anti-microtubule agents for treating or preventing stenosis
Inventor: HUNTER WILLIAM L
IPC: A61K47/34
Filed: 1997-12-02
Abstract: Disclosed is the use of an anti-microtubule agent for the manufacture of a medicament for treating or preventing stenosis, wherein the anti-microtubule agent is selected from the group consisting of campothecin, eleutherobin, sarcodictyins, discodermolide, hexylene glycol (2-methyl-2,4- pentanediol), tubercidin (7-deazaadenosine), LY290181 (2-amino-4-(3-pyridyl)-4H-naphtho(1,2-b)pyran-3-cardonitrile), aluminum fluoride, ethylene glycol bis(succinimidylsuccinate), glycine ethyl ester, microtubule assembly promoting protein (taxol-like protein, TALP), gibberelin, XCHO 1 (kinesin-like protein), lysophosphatidic acid, lithium ion, poly-L-lysine, extensin, glycerol buffers, Triton X-100 microtubule stabilizing buffer, microtubule associated proteins, histone H1, myelin basic protein, kinetochores, endogenous microtubular structures, stable tubule only polypeptide, Nocodazole, Cytochalasin B, CI 980, Colcemid, Podophyllotoxin, Benomyl, Oryzalin, Majusculamide C, Demecolcine, Methyl-2-benzimidazolecarbamate (MBC), and analogues and derivatives thereof, deuterium oxide (D2O) and taxanes other than a paclitaxel or analogues or derivatives thereof, and wherein the anti-microtubule agent is formulated for intraluminal administration.
Patent NZ-539223-A (NZ)
Title: Single copy genomic hybridization probes and method of generating same
Inventor: KNOLL JOAN H
IPC: C12Q1/68
Filed: 2001-05-15
Abstract: A method of determining the existence of a pathological condition or disease predisposition in an individual or their offspring associated with a structural chromosomal abnormality in a human, comprising the steps of: i) Identifying a nucleic acid probe sequence by ascertaining the nucleotide-by-nucleotide sequence of a target nucleic acid sequence; ii) Comparing said ascertained sequences with the sequences of SEQ ID Nos 1-428 and 447-479 in said target nucleic acid sequence using a computer program; iii) Identifying a sequence that is free of SEQ ID Nos 1-428 and 447-479 from said comparison; iv) Developing said genomic nucleic acid probe from said identified sequence, said identified sequence further being complementary to a non-repetitive portion of the target which hybridizes to a least a part of said identified genomic nucleic acid sequence; v) Providing a pair of said genomic nucleic acid probes designed to respectively hybridize on opposite sides of said abnormality, said nucleic acid probe having at least 50 nucleotides, appearing up to three times in a haploid genome, being free of SEQ ID Nos 1-428 and 447-479, and having a known set of sequence coordinated that define the position of said probe in reference to its location on a chromosome without a structural abnormality; vi) Reacting said pair of probes with a chromosomal target sequence containing said abnormality, and causing the probes to hybridize to the target sequence without requiring prehybridizing or cohybridizing of said probes with unlabeled repetitive DNA sequences to provide hybridization specificity; and vii) Detecting said hybridized probes as a way of ascertaining the existence of said chromosome abnormality, wherein the existence of said chromosome abnormality is indicative of the existence of said pathological condition or disease predisposition in said individual or their offspring. (62) Divided Out of 522406
Patent NZ-545176-A (NZ)
Title: Modified antibodies reactive with CD20 and methods of use
Inventor: BRASLAWSKY GARY R
IPC: A61K47/48
Filed: 2002-01-29
Abstract: Disclosed is a modified antibody reactive with CD20 comprising a heavy chain having an amino acid sequence as set from in Fig. 1A. Further disclosed is compositions and methods for treating neoplastic disorders comprising the modified antibody.
Patent NZ-545546-A (NZ)
Title: Method for preparing a coated substrate
Inventor: YONG LAWRENCE JOON LEONG
IPC: A61B19/08
Filed: 2006-02-24
Abstract: A method for preparing a coated substrate (26) is disclosed. The method includes the steps of: (a) providing a substrate (26), (b) extrusion coating a monolithic layer of breathable polymer (28) onto a surface of the substrate (26), and (c) adding maleic anhydride and acrylic ester to the breathable polymer (28) to enhance the melt strength and bond strength of the breathable polymer (28) onto the surface of the substrate (26).
Patent NZ-545783-A (NZ)
Title: A fibre reinforced cement column and method of forming on a lathe automatically adjusting for surface imperfections
Inventor: GLEESON JAMES
IPC: B28B11/12
Filed: 2004-10-08
Abstract: A lathe assembly for forming a fibre reinforced cement elongate tubular body (5) is disclosed. The lathe assembly includes an elongate base (2), a pair of chucks (4), two or more lateral supports, drive means (8) for rotating the body (5) about its longitudinal axis and a profiling tool (9). The chucks (4) are located at opposite longitudinal ends of the base (1) and are configured to engage opposite ends of the tubular body (5). The lateral supports are connected to the base (2) to support the tubular body (5) at two or more support locations between its ends. The profiling tool (9) is connected to the base (2) and engageable to machine or profile the outer circumferential surface of the tubular body (5). The lateral supports take the form of support rollers engageable with the surface of the body (5), one of which is radially movable in response to imperfections in the outer circumferential surface of the body (5).
Patent NZ-547527-A (NZ)
Title: Low-dose tablets having a network of polymers
Inventor: TCHORELOFF PIERRE
IPC: A61K9/22
Filed: 2004-11-10
Abstract: Disclosed are low-dose tablets obtained by directly compressing microgranules essentially constituted of a neutral support covered by a polymeric layer containing at least one pharmaceutically acceptable polymer and permitting the modified release of active substances in an aqueous medium, to which an active layer containing at least one active substance is applied. These tablets advantageously exhibit a matrix effect similar to that obtained with conventional matrix tablets that depends on the nature of the polymer(s) used for the constitution of the polymeric layer. This matrix effect makes it possible to modify the release profile of the transported active substance based on the type of the polymer used. These tablets are particularly suited for realizing low-dose tablets. Also disclosed is a method for producing these tablets and to the use thereof, particularly for administering active substances in low to very low doses.
Patent NZ-551528-A (NZ)
Title: Measuring degree of polymerisation for capsular saccharides that contain sialic acid
Inventor: BARDOTTI ANGELA
IPC: A61K39/095
Filed: 2005-05-23
Abstract: Disclosed is a process for measuring a degree of polymerisation of a capsular saccharide, wherein: (a) the saccharide comprises sialic acid monosaccharide subunits that are linked alpha 2-9; (b) the saccharide has a terminal sialic acid monosaccharide subunit; and (c) the process comprises the steps of: (i) reducing the terminal sialic acid monosaccharide subunit to give a reduced sialic acid monosaccharide subunit; (ii) hydrolysing the saccharide to give a hydrolysate containing monosaccharide subunits, wherein depolymerisation proceeds to completion to thereby produce monosaccharides; and (iii) determining a ratio of total sialic acid to reduced sialic acid in the hydrolysate.
Patent NZ-563270-A (NZ)
Title: Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
Inventor: HAREL AVIKAM
IPC: A61K31/4406
Filed: 2006-05-10
Abstract: Disclosed is a pharmaceutical composition for topical application which comprises calcipotriol (and which may also comprise nicotinamide); and a polyethylene glycol-based dermatologically acceptable carrier, wherein the carrier comprises PEG-4000, PEG-400 and polyoxyethylated stearyl alcohol (Steareth-20). Also disclosed is the use of a topical composition consisting essentially of calcipotriol at a concentration of about 10 mg/g (micrograms per gram) to about 100 mg/g; and nicotinamide at a concentration of about 0.5 mg/g to about 25 mg/g; and a polyethylene glycol-based dermatologically acceptable carrier, wherein the carrier comprises PEG-4000, PEG-400 and polyoxyethylated stearyl alcohol (Steareth-20); to prepare a therapeutic composition for the topical treatment of hyperproliferative disease (such as psoriasis, solar keratosis, ichthyosis, Grover's disease, common warts, keratoacanthoma, seborrhoeic keratosis, scleroderma, and seborrhea).
Patent NZ-564866-A (NZ)
Title: An appartus for providing a sensory stimulation to a subject
Inventor: SMITH KATHRYN LEIGH
IPC: A61M21/00
Filed: 2006-06-05
Abstract: An apparatus for providing therapeutic sensory stimulation to a subject is disclosed. The apparatus comprises a housing and a plurality of sensory stimulation means. The housing is freely moveable across a surface and the sensory stimulation means provides stimulation for one or more of the senses of touch, sight, smell, sound, taste, proprioception or vestibular. The plurality of sensory stimulation means comprises a means for stimulating a first sense and a means for stimulating a second sense where the means for stimulating the first sense is linked with the activation of the means for stimulating the second sense. The sensory stimulation means is disposed within the housing and is adapted for providing sensory stimulants to the environment surrounding the housing and is operable to alter the arousal state of the subject. The housing is provided with a portion that may be opened or removed to access the sensory stimulation means within the housing.